skip to main |
skip to sidebar
INDIANAPOLIS – Christopher A. DiGiusto, director of product and business development at St. Francis Hospital & Health Centers, has been named a Fellow of the American College of Healthcare Executives.
DiGiusto received the credential after fulfilling several requirements, including passing a comprehensive examination, meeting academic and experiential criteria, earning continuing education credits and demonstrating community involvement.
“By becoming a Fellow and simultaneously earning board certification from the ACHE, health-care leaders show they are committed to providing high-quality service to their patients and communities,” said ACHE President Thomas C. Dolan.
The ACHE only has 7,500 fellows nationwide and they must re-certify every three years.
At St. Francis, DiGiusto is responsible for business implementation and development projects with physician practices. He has been associated with the hospital since 2003 and has held several management and consulting positions. He also has served in roles at Community Health Network and the Cincinnati Foundation for Biomedical Research and Education.
An Indianapolis resident, DiGiusto earned his undergraduate degree and master’s of health services administration at Xavier University in Cincinnati where he was an honors student. He’s also an alumnus of Roncalli High School.
C
OLUMBUS, Ind. – Hip and knee pain shouldn’t keep people from leading active and rewarding lives – and St. Francis Hospital & Health Centers wants to show you how.
The St. Francis “Road Show” will be coming to town at 6:30 p.m., Wednesday, June 4, at the Comfort Inn & Suites, 2485 Jonathan Moore Pike. In the spotlight is a hip and knee replacement seminar.
Michael Berend, M.D., will explain the latest procedures in joint replacement and arthritis treatments. He is a board-certified orthopedic surgeon specializing in adult reconstructive surgery and joint replacement.
Berend is a surgeon with Indiana Joint Replacement Surgeons, a practice group whose Center for Hip & Knee Surgery is affiliated with the St. Francis Hospital-Mooresville.
The Center has been ranked No. 1 in Indiana for joint surgery two years in a row by HealthGrades, one of the nation’s premier health-care rating companies.
To register for this seminar, call St. Francis toll-free at 1-877-888-1777.
More information about the Center for Hip & Knee Surgery is at www.stfrancishospitals.org/Ortho/DesktopDefault.aspx?tabid=23.
INDIANAPOLIS – The addition of Indiana Oncology Hematology Consultants (IOHC) further expands the specialty offerings of St. Francis Medical Group.
“We are very pleased to welcome IOHC to the growing family of St. Francis Medical Group practices,” said Kent Brumbaugh, executive director of St. Francis Cancer Care Services. “The IOHC physicians have provided services at St. Francis for many years, but this adds a new dimension to our relationship.”
The merger pools the expertise of physicians and researchers within IOHC and St. Francis Cancer Care Services to form a network of professionals practicing at St. Francis hospitals in Indianapolis, Beech Grove and other locations throughout the state.
“We are indeed excited about the prospects that this merger affords us,” said IOHC President Randall Trowbridge, M.D. “The cancer services that we will be able to provide for our patients and the community has expanded, and we look forward to being an integral part of the cancer program within the St. Francis system.”
The merger brings to St. Francis the top-notch medical services of Laurence H. Bates, M.D.; Maureen Cooper, M.D..; Anita F. Conte, M.D.; Michael T. Slaughter, M.D., Ph.D.; Gregory W. Smith, M.D.; Randall Trowbridge, M.D.; and Johnnie Springman, R.N., family nurse practitioner. In July, Christopher Braden, D.O., will be joining the practice as well. The IOHC physicians treat a wide range of oncologic and hematologic disorders.
IOHC also brings a highly skilled nursing, clinical studies and administrative staff to join forces with St. Francis.
Organized in 1983, IOHC has provided quality health care services to patients throughout Indiana, including two Indianapolis locations: 8111 S. Emerson Ave., Suite A, (in the St. Francis Cancer Care Center) and 9002 N. Meridian St., Suite 214. IOHC physicians also see patients at outreach clinics in Franklin, Batesville, Madison, Elwood, Crawfordsville, Winamac, Frankfort, Kokomo, Rensselaer and Monticello.
Appointments can be scheduled by calling 317-859-5252.
More information about St. Francis Cancer Care Services is at http://stfrancishospitals.org/Cancer.
INDIANAPOLIS – Six students graduated from the St. Francis School of Medical Technology on May 16.
Upon completion of the St. Francis program, the students fulfilled undergraduate degree requirements and will receive bachelor degrees as well. Graduates and their schools:
· Marian College: Wendy Disbro, Aurora, Ind. (received BS in May 2007)
· Purdue University: Ashley Bencik, Greenwood; Scott Grimes, Greensburg; Sarah Homerding, New Lenox, Ill.; Erin McCoy, Elmwood ; and Melissa Stinebaugh, Greentown
The St. Francis School of Medical Technology is affiliated with several colleges and universities across the Midwest. The program, established in 1966, offers a year-long clinical study for participants, during which students attend rotations in various hospital departments.
Medical technology involves conducting a wide range of laboratory tests for the detection, diagnosis, treatment and study of diseases. Medical technologists work closely with pathologists and other specialists to ensure the accuracy of diagnoses.
INDIANAPOLIS – Heart attack patients and others with coronary conditions may benefit from a catheter-based pump device being evaluated in a clinical trial now under way at St. Francis Hospital & Health Centers.
The device is the Impella 2.5, developed by the Massachusetts-based Abiomed Inc. St. Francis is one of the few medical facilities to participate in the PROTECT II trial, the second Food and Drug Administration-approved trial for prophylactic preventive use of the device during non-emergent high-risk coronary intervention procedures.
“We are please to participate in the pivotal PROTECT II trial and we look forward to improving the treatment of high-risk patients,” said principal investigator William J. Berg, M.D., of the Indiana Heart Physicians and St. Francis Heart Center. “The Impella offers physicians a minimally invasive breakthrough technology in cardiac treatment and we’re excited to further demonstrate its effectiveness in this secondary trial.”
The current trial follows Abiomed’s previous PROTECT I trial, which yielded successful results for the ease-of-use and safety of the device, according to company officials.
The Impella 2.5, the world's smallest ventricular assist device (VAD), provides patients with up to 2.5 liters of blood flow per minute. It’s been used to treat more than 1,000 patients in Europe who have had heart attacks and cardiogenic shock, a condition in which a weakened heart cannot pump enough blood to meet the body’s needs.
The trial was approved earlier this year by institutional review board, which oversees all clinical investigations conducted at St. Francis Hospital & Health Centers.
To be eligible for the study, patients must have a left main lesion, only one remaining vessel open, or have triple vessel disease. They also must have a low ejection fraction (below 30 percent or 35 percent, depending on their other qualifying traits).
For more information about the trial, contact Kathy Lawson at 317-851-2582.
More details about the Abiomed’s Impella 2.5 device can be found at www.abiomed.com/products/impella.cfm.
The St. Francis Heart Center is a state-of-the-art facility and the only full-service cardiac and vascular care program on Indianapolis’ south side. For more information about its services go to www.stfrancishospitals.org/Heart.
Editors/Reporters: Still images and DVD B-roll are available
INDIANAPOLIS – Christopher A. DiGiusto, director of product and business development at St. Francis Hospital & Health Centers, has been named a Fellow of the American College of Healthcare Executives.
